[Recommendations for diagnosis and treatment of ankylosing spondylitis]
- PMID: 35922213
- DOI: 10.3760/cma.j.cn112138-20211226-00913
[Recommendations for diagnosis and treatment of ankylosing spondylitis]
Abstract
Ankylosing spondylitis (AS) is a chronic inflammatory disease mainly affecting the sacroiliac joints, spine and peripheral joints. In China, standardized diagnosis and treatment of AS is still to be popularized. Based on the evidence and guidelines from China and other countries, Chinese Rheumatology Association developed standardization of diagnosis and treatment of AS. The purposes are: (1) to standardize the diagnosis and evaluation of AS; (2) to promote rational use of non-steroidal anti-inflammatory drugs, biological as well as traditional disease modifying anti-rheumatic drugs, so as to improve the patient's quality of life.
强直性脊柱炎(AS)是一种主要侵犯骶髂关节、脊柱和外周关节的慢性炎症性疾病。在我国,AS的规范化诊断和治疗仍有待普及。中华医学会风湿病学分会结合我国国情,在借鉴国内外诊治经验和指南的基础上,制定了本规范,旨在规范AS的诊断和病情评估,合理使用非甾体抗炎药、生物和传统合成改善病情抗风湿药,提高患者的生活质量。.
Similar articles
-
The role of secukinumab in the treatment of ankylosing spondylitis.Immunotherapy. 2015;7(12):1241-7. doi: 10.2217/imt.15.93. Epub 2015 Nov 23. Immunotherapy. 2015. PMID: 26595091
-
Marked reduction of sacroiliac joint inflammation on magnetic resonance imaging in a patient with ankylosing spondylitis after rituximab treatment.J Rheumatol. 2011 Sep;38(9):2083-4. doi: 10.3899/jrheum.110132. J Rheumatol. 2011. PMID: 21885528 No abstract available.
-
The treatment of ankylosing spondylitis.Clin Exp Med. 2003 Feb;2(4):159-65. doi: 10.1007/s102380300000. Clin Exp Med. 2003. PMID: 12624705 Review.
-
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update.Joint Bone Spine. 2007 Dec;74(6):638-46. doi: 10.1016/j.jbspin.2007.10.003. Epub 2007 Nov 8. Joint Bone Spine. 2007. PMID: 18065252
-
Ankylosing spondylitis.Lancet. 2007 Apr 21;369(9570):1379-1390. doi: 10.1016/S0140-6736(07)60635-7. Lancet. 2007. PMID: 17448825 Review.
Cited by
-
Comparative real-world retention rate and safety of biosimilar IBI303 versus Humira in ankylosing spondylitis: A retrospective study.Medicine (Baltimore). 2025 Jun 27;104(26):e43010. doi: 10.1097/MD.0000000000043010. Medicine (Baltimore). 2025. PMID: 40587746 Free PMC article.
-
Breaking boundaries in ankylosing spondylitis: how innovative cell therapies reshape immunity, drive cutting-edge advances, and face future challenges.Front Immunol. 2025 Jul 11;16:1613502. doi: 10.3389/fimmu.2025.1613502. eCollection 2025. Front Immunol. 2025. PMID: 40718480 Free PMC article. Review.
-
Clinical value of the Patient Global Assessment with Ankylosing Spondylitis: A cross-sectional study.Medicine (Baltimore). 2024 Apr 19;103(16):e37791. doi: 10.1097/MD.0000000000037791. Medicine (Baltimore). 2024. PMID: 38640261 Free PMC article.
-
Prevalence, influencing factors, and prediction model construction of anemia in ankylosing spondylitis based on real-world data: An exploratory study.PLoS One. 2025 Feb 5;20(2):e0318332. doi: 10.1371/journal.pone.0318332. eCollection 2025. PLoS One. 2025. PMID: 39908327 Free PMC article.
-
Assessing and Optimizing Large Language Models on Spondyloarthritis Multi-Choice Question Answering: Protocol for Enhancement and Assessment.JMIR Res Protoc. 2024 May 24;13:e57001. doi: 10.2196/57001. JMIR Res Protoc. 2024. PMID: 38788208 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials